文献速递肝病

非酒精性脂肪性肝病与非酒精性脂肪性肝炎的全球视角——患病率、临床影响、经济负担和管理策略

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies.
PubMed 文献 · Aliment Pharmacol Ther · 2024-01-01

综述指出非酒精性脂肪性肝病(NAFLD)影响全球38%成人,可进展为NASH、肝移植、肝癌及肝相关死亡,并降低生活质量、增加医疗资源利用。筛查高危NAFLD(F2及以上纤维化)势在必行,应采用风险分层算法在初级保健和内分泌科识别患者并启动生活方式及心血管代谢危险因素管理。

要点

  • NAFLD影响全球38%成人,是慢性肝病最常见病因,可进展为NASH、肝移植、肝癌及肝相关死亡。
  • 筛查高危NAFLD(F2及以上纤维化)势在必行,风险分层算法应在初级保健和内分泌科使用。
  • NAFLD经济影响来自直接和间接医疗成本及工人生产力损失,未来二十年NAFLD与糖尿病总成本预计超1.5万亿美元。

核心结论

  • 为减少NAFLD/NASH日益增长的负担,管理应包括风险分层算法以准确识别患者、连接适当诊疗环境并启动有效治疗方案。

研究设计与样本

  • 综述:通过PubMed检索NAFLD、患病率、临床负担、经济负担和管理策略相关文章。

主要发现

  • NAFLD影响全球38%成人,可进展为NASH、肝移植、肝癌、肝相关死亡,并因躯体功能受损降低生活质量、增加医疗资源利用。
  • NAFLD/NASH呈全球地理差异,南美洲和中东及北非患病率最高,非洲最低。
  • NAFLD经济影响来自直接和间接医疗成本及工人生产力损失,未来二十年NAFLD与糖尿病总成本预计超1.5万亿美元(美元)。
  • 识别高危NAFLD的风险分层算法基于NAFLD识别和纤维化发展的无创检测制定。

关键数值与推荐

  • 筛查NAFLD成本过高,但筛查高危NAFLD(NAFLD伴F2及以上纤维化)势在必行。
  • 风险分层算法应在初级保健和内分泌科环境中使用,以便及时启动生活方式和心血管代谢危险因素管理等适当干预。

临床怎么用

  • 风险分层算法应在初级保健和内分泌科环境中使用,以便及时启动生活方式和心血管代谢危险因素管理等适当干预。
  • 管理应包括风险分层算法以准确识别患者、连接适当诊疗环境并启动有效治疗方案。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The metabolically-based liver disease, nonalcoholic fatty liver disease (NAFLD), is the most common cause of chronic liver disease currently affecting 38% of the world's adult population. NAFLD can be progressive leading to nonalcoholic steatohepatitis (NASH), liver transplantation, liver cancer, liver-related mortality and is associated with decreased quality of life from impaired physical functioning and increased healthcare resource utilisation. However, screening for NAFLD is cost-prohibitive but screening for high risk NAFLD (NAFLD with F2 fibrosis or greater) is imperative. AIM: To review the global perspective on NAFLD and NASH METHODS: We retrieved articles from PubMed using search terms NAFLD, prevalence, clinical burden, economic burden and management strategies. RESULTS: NAFLD/NASH shows geographical variation across the globe. Highest prevalence rates are in South America and the Middle East and North Africa; lowest prevalence is in Africa. NAFLD's economic impact is from direct and indirect medical costs and loss in worker productivity. It is projected that, over the next two decades, the total cost of NAFLD and diabetes will exceed $1.5 trillion (USD). Risk stratification algorithms identifying "high risk NAFLD" were made following non-invasive tests for NAFLD identification and fibrosis development. These algorithms should be used in primary care and endocrinology settings so timely and appropriate interventions (lifestyle and cardiometabolic risk factor management) can be initiated. CONCLUSIONS: To reduce the burgeoning burden of NAFLD/NASH, management should include risk stratification algorithms for accurate identification of patients, linkage to appropriate settings, and initiation of effective treatment regimens.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Golabi P, Owrangi S, Younossi ZM, et al. Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Aliment Pharmacol Ther. 2024. PMID: 38813821. doi:10.1111/apt.17833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。